Velarion Records
Free. Unsubscribe any time.

Prime Medicine, Inc. (PRME)

Prime Medicine, Inc. filed 4 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 1 reporting owner, covering 4 transactions and 84,000 shares. None carries the SEC's AFF10B5ONE flag; all 4 name a plan in a footnote. 8 results prints are on file in the same window.

What stands out

Trades in Prime Medicine, Inc. 4

Adoption dates in Prime Medicine, Inc. 1

Results prints in Prime Medicine, Inc. 8

Trades before a print in Prime Medicine, Inc. 0

Interval to Prime Medicine, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Prime Medicine, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on March 3, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.